Infertility Clinical Trial
Official title:
Low Level Laser Therapy to Endometrial Cells: A Novel Approach to Increase Endometrial Proliferation and Enhance Endometrial Receptivity
The human endometrium is an extremely sensitive target. LLLT can enhance the proliferation
rate of various cell lines, it produces higher rates of ATP, RNA, and DNA synthesis in stem
cells and other cell lines. Thus, LLLT improves the proliferation of the cells without
causing any cytotoxic effects.
The aim of this work is to assess the ability of low level laser therapy in enhancing
endometrial proliferation and increasing endometrial receptivity.
A number of 120 human endometrial samples will be studied, and will be collected from 40
infertile women attending the infertility clinic at NRC. Each human endometrial sample will
be divided into 3 plates, in order to establish 3 main groups of 40 culture plates for single
laser exposure group versus 40 culture plates for multiple laser exposure group and 40 tissue
culture plates for control samples, thus a total of 120 tissue culture plates will be
studied, the study groups will be exposed to low level laser therapy and compared to their
matched controls.. Assessment of number and size of cells after LLLT as a marker of normal
proliferation and b) The expression of Integrin aVB3 "alpha v B3", MUC-1 and LIFand the
development of pinopodes on the surface of epithelial cells as markers of endometrial
receptivity and the detection of PTEN tumor suppressor gene as a marker of abnormal
proliferation or premalignant condition will be performed to assess the effect of LLLT on the
endometrial cell culture. This study might offer a new therapeutic modality which might
increase endometrial thickness and enhance receptivity .
Plan of work:
A number of 40 human endometrial samples will be collected from 40 infertile women attending
the infertility clinic at the National Research Center (each sample will be divided into 3
culture plates; single exposure group, multiple exposure group and control group) and will be
included in the study.
Each human endometrial sample will be divided into 3 plates, in order to establish 3 main
groups of 40 culture plates for single laser exposure group versus 40 culture plates for
multiple laser exposure group and 40 tissue culture plates for control samples, thus a total
of 120 tissue culture plates will be studied, the study groups will be exposed to low level
laser therapy and compared to their matched controls.
Timing of endometrial tissue sample:
Endometrial tissue biopsy will be performed in the early proliferative phase just after
menstruation ceases (from day 5 to day8).
Consent A written informed consent will be obtained from each woman before the procedure. The
consent will explain the purpose from the procedure, the aim from the research and the
possible side effects.
Endometrial cell culture:
Endometrial biopsy strips will be collected from women included in the study. The endometrial
biopsy strips will be taken from the uterine wall using pipelle.
Endometrial tissue will be transported to the laboratory in isolation media. Endometrial
tissue will be stored at 4°C, and processed within 2-10 h.
Clusters of cells will be considered colonies when they become visible macroscopically and
contain greater than 50 cells.
The same culture condition will be applied to both study and control samples. The tissue
culture will be discarded after 14 days when the study will be completed.
Low level laser therapy will be wavelength 635nm diode laser, power of 40mw will be tested on
cultured endometrial cells in Petri dish S.A. of 9.62cm2 with fluence rate of 4.2 J/cm2 in
the continuous mode, depth of penetration at 635nm ranges from 1 to 6mm.
Tissue cultures in the study group will be divided into 2 groups; The 1st group will be
composed of 40 tissue culture plates and will be exposed to the total fluence dose 4.2 J/cm2
in a single session of 16 minutes duration with low level therapy machine adjusted at power
of 40mw. The 2nd group will be composed of another 40 tissue culture plates, they will be
exposed to the same fluence rate but in multiple sessions ''3 sessions'', which will be
performed every other day, each session will last for approximately 5.34 minutes using low
level laser of power of 40mw to reach the same fluence dose of 4.2 J/cm2 after finishing the
3rd session.
Single versus multiple exposures of LLLT will be tested in the endometrial culture plates and
will be compared to control group not exposed to laser. Comparison between single session
exposure and multiple sessions' exposure is important in order to determine the benefits over
the risk of multiple exposures sessions in thin endometrium in vivo, being an invasive
procedure and requiring a fibro-optic probe insertion inside the uterus which might cause
some discomfort to the patient and could be affected by patient's compliance.
RT-PCR Analysis technique and steps:
Real time PCR will be used to screen and detect the presence of endometrial implantation
markers namely the expression of Integrin aVB3 "alpha v B3", MUC-1, LIF and also the
expression of PTEN tumor suppressor gene as an early marker for premalignant endometrial
disease.
Electron microscopy; Cells in tissue culture will be examined by electron microscope in order
to detect the presence of pinopodes as a marker of increased endometrial receptivity.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A |